Maas R - Search Results

1

Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.

Schwedhelm E, Xanthakis V, Maas R, Sullivan LM, Atzler D, Lüneburg N, Glazer NL, Riederer U, Vasan RS, Böger RH. Schwedhelm E, et al. Among authors: maas r. Clin Chem Lab Med. 2011 Nov;49(11):1907-10. doi: 10.1515/CCLM.2011.679. Epub 2011 Aug 25. Clin Chem Lab Med. 2011. PMID: 21864208 Free PMC article.

2

Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease.

Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Salvatore Malatino L, Böger R. Zoccali C, et al. Among authors: maas r. J Am Soc Nephrol. 2002 Feb;13(2):490-496. doi: 10.1681/ASN.V132490. J Am Soc Nephrol. 2002. PMID: 11805179

3

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.

Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Böger R; CREED Investigators. Zoccali C, et al. Among authors: maas r. Kidney Int. 2002 Jul;62(1):339-45. doi: 10.1046/j.1523-1755.2002.00437.x. Kidney Int. 2002. PMID: 12081596 Free article.

4

The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.

Maas R, Schwedhelm E, Albsmeier J, Böger RH. Maas R, et al. Vasc Med. 2002 Aug;7(3):213-25. doi: 10.1191/1358863x02vm429ra. Vasc Med. 2002. PMID: 12553745 Review.

5

Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Schwedhelm E, Maas R, Troost R, Böger RH. Schwedhelm E, et al. Among authors: maas r. Clin Pharmacokinet. 2003;42(5):437-59. doi: 10.2165/00003088-200342050-00003. Clin Pharmacokinet. 2003. PMID: 12739983 Review.

6

Antihypertensive therapy: special focus on drug interactions.

Maas R, Böger RH. Maas R, et al. Expert Opin Drug Saf. 2003 Nov;2(6):549-79. doi: 10.1517/14740338.2.6.549. Expert Opin Drug Saf. 2003. PMID: 14585065 Review.

7

Old and new cardiovascular risk factors: from unresolved issues to new opportunities.

Maas R, Böger RH. Maas R, et al. Atheroscler Suppl. 2003 Dec;4(4):5-17. doi: 10.1016/s1567-5688(03)00028-x. Atheroscler Suppl. 2003. PMID: 14664897 Review.

8

Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease.

Mallamaci F, Tripepi G, Maas R, Malatino L, Böger R, Zoccali C. Mallamaci F, et al. Among authors: maas r. J Am Soc Nephrol. 2004 Feb;15(2):435-41. doi: 10.1097/01.asn.0000106717.58091.f6. J Am Soc Nephrol. 2004. PMID: 14747391

9

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.

Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, Böger RH. Schwedhelm E, et al. Among authors: maas r. Circulation. 2004 Feb 24;109(7):843-8. doi: 10.1161/01.CIR.0000116761.93647.30. Epub 2004 Feb 2. Circulation. 2004. PMID: 14757688

10

Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia.

Maas R, Böger RH, Schwedhelm E, Casas JP, López-Jaramillo P, Serrano N, Díaz LA. Maas R, et al. JAMA. 2004 Feb 18;291(7):823-4. doi: 10.1001/jama.291.7.823. JAMA. 2004. PMID: 14970060 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

788 results

Search Page

Filters